Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
5898 items from SEC EDGAR · clear filters
- 8-K - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Lexicon Pharmaceuticals filed a Form 8-K on August 6, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - MACOM Technology Solutions Holdings, Inc. (0001493594) (Filer)
MACOM Technology Solutions Holdings, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - COLLEGIUM PHARMACEUTICAL, INC (0001267565) (Filer)
Colleium Pharmaceutical, Inc. filed a Form 8-K on August 6, 2026. The filing includes Item 2.02 reporting results of operations and financial condition, and Item 7.01 containing a Regulation FD disclosure.
- 8-K - Cronos Group Inc. (0001656472) (Filer)
Cronos Group Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition) and Item 9.01 (financial statements and exhibits).
- 8-K - Optimum Communications, Inc. (0001702780) (Filer)
Optimum Communications, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Cheniere Energy Partners, L.P. (0001383650) (Filer)
Cheniere Energy Partners, L.P. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition for the period and attaching the related financial statements and exhibits.
- 8-K - Installed Building Products, Inc. (0001580905) (Filer)
Installed Building Products, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02), a Regulation FD disclosure (Item 7.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - RE/MAX Holdings, Inc. (0001581091) (Filer)
RE/MAX Holdings, Inc. filed a Form 8-K with the SEC on August 6, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001104659-26-091642, 304 KB).
- 8-K - Commerce.com, Inc. (0001626450) (Filer)
Commerce.com, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - OPEN TEXT CORP (0001002638) (Filer)
Open Text Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Zoetis Inc. (0001555280) (Filer)
Zoetis Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Cullinan Therapeutics filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Vistance Networks, Inc. (0001517228) (Filer)
Vistance Networks filed a Form 8-K reporting departures and appointments of officers and directors, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - Smith Douglas Homes Corp. (0001982518) (Filer)
Smith Douglas Homes Corp. filed a Form 8-K on August 6, 2026, including Item 2.02 detailing its results of operations and financial condition, and Item 9.01 providing its financial statements and related exhibits.
- 8-K - Shift4 Payments, Inc. (0001794669) (Filer)
Shift4 Payments, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Core Natural Resources, Inc. (0001710366) (Filer)
Core Natural Resources, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - BENTLEY SYSTEMS INC (0001031308) (Filer)
Bentley Systems Inc. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and attaching its financial statements and related exhibits.
- 8-K - Resolute Holdings Management, Inc. (0002039497) (Filer)
Resolute Holdings Management, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Iovance Biotherapeutics filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).
- 8-K - Tecnoglass Holdings Inc. (0001534675) (Filer)
Tecnoglass Holdings Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and exhibits (Item 9.01).
- 8-K - BlackSky Technology Inc. (0001753539) (Filer)
BlackSky Technology Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001753539-26-000118), reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Vital Farms, Inc. (0001579733) (Filer)
Vital Farms, Inc. filed a Form 8-K reporting entry into and termination of material definitive agreements, disclosed its results of operations and financial condition, created a direct financial obligation/off-balance-sheet arrangement, and provided related financial statements and exhibits.
- 8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Viridian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)
Ligand Pharmaceuticals Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Opus Genetics, Inc. (0001228627) (Filer)
Opus Genetics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and exhibits.
- 8-K - Korro Bio, Inc. (0001703647) (Filer)
Korro Bio, Inc. filed a Form 8-K reporting a material definitive agreement, its results of operations and financial condition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Warner Bros. Discovery, Inc. (0001437107) (Filer)
Warner Bros. Discovery, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)
Monte Rosa Therapeutics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - Evolent Health, Inc. (0001628908) (Filer)
Evolent Health, Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001628908-26-000084) containing Item 2.02 on results of operations and financial condition and Item 9.01 with its financial statements and exhibits.
- 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Cartesian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition and including its financial statements and related exhibits.